Jump to content

New Marijuana Mouthspray Being Reviewed by FDA

Recommended Posts



. . . . . . . . .

A new marijuana mouth spray aimed at relieving pain is being reviewed by the U.S. Food and Drug Administration in clinical trials, USA Today reported.

Sativex is one-part tetrahydrocannabinol, which is the main chemical responsible for the “high” that marijuana users feel, and one-part cannabidiol, a related-compound.

However, British manufacturers GW Pharmaceutica said the drug won’t make its users feel high. Its intended goal is to treat pain and relieve symptoms from ailments such as Alzheimer’s, Parkinson’s and Huntington’s diseases.

Sativex is approved in Canada for two groups of patients — adults with advanced cancer who feel moderate to severe pain and are taking the highest narcotic dose they can tolerate, and adults with multiple sclerosis with nerve pain.

Currently, there are two synthetic cannabinoid pills in the United States — Marinol and Cesamet, which are FDA-approved to treat chemotherapy-induced nausea and vomiting. Marinol also is FDA-approved to treat appetite loss associated with AIDS.

. . . . . . . . .

(Fox News, July 17, 2008)


The information contained in these articles may or may not be in agreement with my own opinions. They are not posted as medical advice of any kind.

Link to comment
Share on other sites

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Reply to this topic...

×   Pasted as rich text.   Restore formatting

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

  • Create New...

Important Information

By using this site, you agree to our Terms of Use. We have placed cookies on your device to help make this website better. You can adjust your cookie settings, otherwise we'll assume you're okay to continue.